1
|
Li YM, Li YX, Li DY, Zhou Y, An L, Yuan ZY, Du KM, Zheng ZZ. Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population. PLoS One 2024; 19:e0281698. [PMID: 38593173 PMCID: PMC11003630 DOI: 10.1371/journal.pone.0281698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2023] [Accepted: 02/10/2024] [Indexed: 04/11/2024] Open
Abstract
Several genes involved in the pathogenesis have been identified, with the human leukocyte antigen (HLA) system playing an essential role. However, the relationship between HLA and a cluster of hematological diseases has received little attention in China. Blood samples (n = 123913) from 43568 patients and 80345 individuals without known pathology were genotyped for HLA class I and II using sequencing-based typing. We discovered that HLA-A*11:01, B*40:01, C*01:02, DQB1*03:01, and DRB1*09:01 were prevalent in China. Furthermore, three high-frequency alleles (DQB1*03:01, DQB1*06:02, and DRB1*15:01) were found to be hazardous in malignant hematologic diseases when compared to controls. In addition, for benign hematologic disorders, 7 high-frequency risk alleles (A*01:01, B*46:01, C*01:02, DQB1*03:03, DQB1*05:02, DRB1*09:01, and DRB1*14:54) and 8 high-frequency susceptible genotypes (A*11:01-A*11:01, B*46:01-B*58:01, B*46:01-B*46:01, C*01:02-C*03:04, DQB1*03:01-DQB1*05:02, DQB1*03:03-DQB1*06:01, DRB1*09:01-DRB1*15:01, and DRB1*14:54-DRB1*15:01) were observed. To summarize, our findings indicate the association between HLA alleles/genotypes and a variety of hematological disorders, which is critical for disease surveillance.
Collapse
Affiliation(s)
- Ye-Mo Li
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | - Yu-Xia Li
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Dai-Yang Li
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | - Ying Zhou
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Zhi-Yang Yuan
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | - Ke-Ming Du
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | | |
Collapse
|
2
|
Wang HC, Ma RY, Zhai HL, Zheng ZZ, Wei R. The novel HLA-DPB1*02:02:07 allele identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 102:777-778. [PMID: 37622239 DOI: 10.1111/tan.15202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Accepted: 08/08/2023] [Indexed: 08/26/2023]
Abstract
HLA-DPB1*02:02:07 differs from HLA-DPB1*02:02:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Hou-Cai Wang
- Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| | - Ru-Ye Ma
- Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| | - Hui-Li Zhai
- Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| | | | - Rong Wei
- Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| |
Collapse
|
3
|
Ruan M, Zhang LL, Li YM, Li DY, Yuan ZY, Zheng ZZ, Zeng QS. [Detection of BCR-ABL Fusion Gene in Chronic Myeloid Leukemia by Novel Digital PCR]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2023; 31:1647-1656. [PMID: 38071041 DOI: 10.19746/j.cnki.issn.1009-2137.2023.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/18/2023]
Abstract
OBJECTIVE To establish a new digital polymerase chain reaction (dPCR) system for the detection of BCR-ABL fusion gene in patients with chronic myeloid leukemia (CML), and explore its analytical performance and clinical applicability in the detection of BCR-ABLp190/210/230. METHODS A new dPCR system for detecting BCR-ABLp190/210/230 was successfully developed, and its sensitivity difference with qPCR and improvement of drug side effects in patients with CML during drug reduction or withdrawal were compared. RESULTS Among 176 samples, qPCR and dPCR showed high consistency in the sensitivity of detecting BCR-ABL (82.39%), and the positive rate of dPCR was about 5 times higher that of qPCR (20.45% vs 3.98%). During follow-up, blood routine (25% vs 10%), kidney/liver/stomach (25% vs 20%) and cardiac function (10% vs 0) were significantly improved after drug reduction or withdrawal in patients with initial dPCR negative compared with before drug reduction or withdrawal. CONCLUSIONS This new dPCR detection system can be applied to the detection of BCR-ABLp190/210/230. It has better consistency and higher positive detection rate than qPCR. Drug withdrawal or dose reduction guided by dPCR has a certain effect on improving drug side effects.
Collapse
Affiliation(s)
- Min Ruan
- Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China
| | - Li-Li Zhang
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai 201318, China
| | - Ye-Mo Li
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai 201318, China
| | - Dai-Yang Li
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai 201318, China
| | - Zhi-Yang Yuan
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai 201318, China
| | | | - Qing-Shu Zeng
- Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China.E-mail:
| |
Collapse
|
4
|
Cao J, Xu X, Lu Y, Wang T, Chen D, Li S, Liu X, Ye P, Zheng ZZ, Pei R. Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia. Hematology 2023; 28:2223873. [PMID: 37347232 DOI: 10.1080/16078454.2023.2223873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/23/2023] Open
Abstract
OBJECTIVE Post-transplantation cyclophosphamide (PTCy) can reduce the incidence of graft versus host disease (GVHD) and this intervention is often applied on adults with hematologic malignancy. However, the high relapse rate hinders the development of the intervention and data of PTCy used on children with hematologic malignancy remains limited. In order to overcome issue of high relapse rate in PTCy treatment, we used fludarabine (Flu), enhanced dose of cytarabine (Ara-C, 9 g/m2), busulfan (Bu), Cy, anti-thymocyte globulin (ATG) combined with PTCy for an intensified conditioning regimen. METHODS A total of 22 children with acute leukemia received intensified PTCy conditioning regimen (PTCy intensified group). We matched with 18 children who received modified Bu-Cy and ATG conditioning regimen in the same period (ATG group). RESULTS The two-year cumulative incidences of grade II-IV acute GVHD was significantly lower in PTCy intensified group (13.6 ± 7.7% vs 38.9 ± 11.5%, P = 0.048). Two-year GVHD-free relapse free survival (GRFS) in PTCy seems to be better among the increment group despite not being significant (63.3 ± 10.3% vs 35.4 ± 11.9%, P = 0.092). The positive rate of minimal residual disease after transplantation was significantly lower than that before transplantation (20.0% vs 2.5%, P = 0.029). CONCLUSION In conclusion, ATG and PTCy combined with Flu-based increased intensity conditioning regimen is effective for acute leukemia in children. It could reduce GVHD rate significantly and potentially improve GRFS.
Collapse
Affiliation(s)
- Junjie Cao
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Xiaodong Xu
- Department of Oncology, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China
| | - Ying Lu
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Tiantian Wang
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Dong Chen
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Shuangyue Li
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Xuhui Liu
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Peipei Ye
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| | - Zhong-Zheng Zheng
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, People's Republic of China
| | - Renzhi Pei
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China
- Institute of Hematology, Ningbo University, Ningbo, People's Republic of China
| |
Collapse
|
5
|
Wang X, Xiao Q, Du KM, Zheng ZZ, Wang L. The novel HLA-DQB1*06:475 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 102:645-646. [PMID: 37537849 DOI: 10.1111/tan.15172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 07/19/2023] [Indexed: 08/05/2023]
Abstract
HLA-DQB1*06:475 differs from HLA-DQB1*06:35 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Xin Wang
- Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Qing Xiao
- Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | | | - Li Wang
- Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
6
|
Li ZF, Feng JK, Zhao XC, Liu W, Gu SA, Li R, Lu YL, Mao RJ, Xia LL, Dong LL, Zhang LW, Ruan JY, Liu J, Li GF, Li T, Sun R, Qiu SL, Zheng ZZ, Dong T. The Extract of Pinellia Ternata-Induced Apoptosis of Leukemia Cells by Regulating the Expression of Bax, Bcl-2 and Caspase-3 Protein Expression in Mice. Transplant Proc 2023; 55:2232-2240. [PMID: 37777366 DOI: 10.1016/j.transproceed.2023.08.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Revised: 07/17/2023] [Accepted: 08/01/2023] [Indexed: 10/02/2023]
Abstract
The study aims to lessen the monetary burden on patients and society by decreasing the price of proprietary drugs used in leukemia therapy. Flow cytometry, reverse transcription polymerase chain reaction, western blot, and a patient-derived xenograft mouse model were used to confirm the therapeutic effect of Pinellia ternata extract on leukemia. Three types of leukemia cells (K562, HL-60, and C8166 cell lines) were found to undergo early apoptosis (P ≤ .05) after being exposed to P. ternata extract, as measured by flow cytometry. Reverse transcription polymerase chain reaction results showed that P. ternata extract at both middle (300 μg/mL) and high (500 μg/mL) concentrations was able to down-regulate Bcl-2 and upregulate mRNA expression of Bax and caspase-3. In the patient-derived xenograft mouse model formed by BALB/c-nu/nu nude mice, immunohistochemistry indicated that P. ternata extract effectively suppressed the proliferation of leukemia cells. Therefore, P. ternata extract at 300 μg/mL and 500 μg/mL could effectively inhibit myeloid and lymphocytic leukemia cell proliferation and promote leukemia cell apoptosis by regulating Bax/Bcl-2 and caspase-3.
Collapse
Affiliation(s)
- Zheng-Fa Li
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Jia-Kun Feng
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Xiao-Chen Zhao
- Yunnan University of Chinese Medicine, Kunming, Yunnan, China
| | - Wei Liu
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Shi-An Gu
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Rui Li
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Yang-Liu Lu
- Yunnan University of Chinese Medicine, Kunming, Yunnan, China
| | - Rui-Jiao Mao
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China
| | - Li-Ling Xia
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Lu-Lu Dong
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Li-Wen Zhang
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Jing-Yan Ruan
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Jiao Liu
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Guang-Fen Li
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Tao Li
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Rong Sun
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | - Shui-Lan Qiu
- Department of Hematology, Department of Pathology of Yunnan New Kun Hua Hospital, Kunming, Yunnan, China
| | | | - Ting Dong
- Department of Hematology, Department of Laboratory of the First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan, China.
| |
Collapse
|
7
|
Wang YQ, Huang JY, Du KM, Zheng ZZ, Cai XH. The novel HLA-B*40:536N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 102:524-525. [PMID: 37381595 DOI: 10.1111/tan.15141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 06/19/2023] [Indexed: 06/30/2023]
Abstract
HLA-B*40:536N differs from HLA-B*40:03:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Yu-Qing Wang
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| | - Jia-Yu Huang
- Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | | | - Xiao-Hong Cai
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
8
|
Lou C, He Y, Du KM, Zheng ZZ, Gong S. The novel HLA-A*30:01:24 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 102:516-517. [PMID: 37533399 DOI: 10.1111/tan.15161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2023] [Accepted: 07/11/2023] [Indexed: 08/04/2023]
Abstract
HLA-A*30:01:24 differs from HLA-A*30:01:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Can Lou
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Yang He
- Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | | | - Songsong Gong
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
9
|
Cheng J, Zheng ZZ, Du KM, An L, Liu HJ. The novel HLA-C*04:01:152 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 102:533-534. [PMID: 37515486 DOI: 10.1111/tan.15170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 07/19/2023] [Indexed: 07/31/2023]
Abstract
HLA-C*04:01:152 differs from HLA-C*04:01:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Jie Cheng
- Department of Hematology and Oncology, Anhui Provincial Children's Hospital (Anhui Hospital, Pediatric Hospital of Fudan University), Hefei, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Hong-Jun Liu
- Department of Hematology and Oncology, Anhui Provincial Children's Hospital (Anhui Hospital, Pediatric Hospital of Fudan University), Hefei, China
| |
Collapse
|
10
|
Gao CL, Du KM, Zheng ZZ, Bi H, Zhou ZP. The novel HLA-A*68:302 allele, identified by Sanger dideoxynucleotide sequencing in a Chinese individual. HLA 2023; 102:517-519. [PMID: 37403794 DOI: 10.1111/tan.15139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 06/13/2023] [Accepted: 06/14/2023] [Indexed: 07/06/2023]
Abstract
HLA-A*68:302 differs from HLA-A*68:01:02:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Chun-Lin Gao
- Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Department of Oncology, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | | | - Hui Bi
- Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| | - Ze-Ping Zhou
- Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| |
Collapse
|
11
|
Jiang C, Zhao KQ, Zhao HL, Zheng ZZ, Zhao XH, Wu WW. [Relationship between carotid atherosclerotic plaque characteristics in magnetic resonance imaging and perioperative hemodynamic instability]. Zhonghua Yi Xue Za Zhi 2023; 103:1918-1924. [PMID: 37402673 DOI: 10.3760/cma.j.cn112137-20221208-02600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 07/06/2023]
Abstract
Objective: To analyze the relationship between carotid atherosclerotic plaque characteristics in magnetic resonance imaging (MRI) and perioperative hemodynamic instability in patients with severe carotid artery stenosis undergoing carotid artery stenting (CAS). Methods: A total of 89 patients with carotid artery stenosis who underwent CAS treatment at Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University from January 1, 2017, to December 31, 2021, were prospectively included. Among them, 74 were male and 15 were female, with an age range of 43 to 87 years (mean age: 67.8±8.2 years). Preoperative examinations included carotid artery MRI vessel wall imaging to analyze the existence of large lipid-rich necrotic core (LRNC), intraplaque hemorrhage (IPH), and fibrous cap rupture in carotid artery plaques. Plaques without the above-mentioned risk factors were defined as stable plaque group (34 cases), while those with such risk factors were defined as vulnerable plaque group (55 cases). The number of risk factors present in each plaque was also calculated. Intraoperative changes in blood pressure and heart rate were recorded, and the use of dopamine postoperatively was noted. Using the risk factors that the plaque has as independent variables and the clinical outcomes as dependent variables, the RR values were calculated, and the differences in clinical outcomes of patients with different risk factors were compared. Results: The incidence rates of hypotension and bradycardia were higher in patients with vulnerable plaques than those with stable plaques (60.0% (33/55) vs 14.7%(5/34) and 38.2%(21/55) vs 14.7%(5/34), respectively; both P<0.05). Based on MRI imaging features, the large LRNC was present in 45 cases, with RR values for hypotension and bradycardia of 3.15 (1.69-5.87) and 2.20 (1.07-4.53), respectively; IPH was present in 37 cases, with RR values for hypotension and bradycardia of 2.70 (1.61-4.55) and 2.25 (1.15-4.39), respectively; and fibrous cap rupture was present in 29 cases, with RR values for hypotension and bradycardia of 1.50 (0.94-2.40) and 1.29 (0.67-2.49), respectively. The higher the number of risk factors in vulnerable plaques, the higher the incidence of intraoperative blood pressure and heart rate decrease: when the number of risk factors ranged from 0 to 3, the incidence of blood pressure decrease was 14.7% (5/34), 9/18, 11/18, and 13/19, respectively (P<0.001), and the incidence of heart rate decrease was 14.7% (5/34), 6/18, 7/18, and 8/19, respectively (P=0.022). There was no significant difference in the number of cases of dopamine use between the two groups (P>0.05). Conclusion: Patients with a higher number of risk factors for vulnerable carotid plaques, as indicated by carotid artery MRI vessel wall imaging, are at a higher risk of experiencing blood pressure and heart rate decrease during CAS surgery.
Collapse
Affiliation(s)
- C Jiang
- Department of Vascular Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
| | - K Q Zhao
- Department of Vascular Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
| | - H L Zhao
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
| | - Z Z Zheng
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
| | - X H Zhao
- Center for Biomedical Imaging Research, Tsinghua University, Beijing 100084, China
| | - W W Wu
- Department of Vascular Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
| |
Collapse
|
12
|
Li YM, Li YX, Hu XZ, Li DY, An L, Yuan ZY, Liu ZL, Du KM, Zheng ZZ. Exploration of KIR genes and hematological-related diseases in Chinese Han population. Sci Rep 2023; 13:9773. [PMID: 37328612 PMCID: PMC10276034 DOI: 10.1038/s41598-023-36882-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 06/12/2023] [Indexed: 06/18/2023] Open
Abstract
The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-related diseases, herein, a multi-center retrospective study in China was conducted, analyzing and comparing 2519 patients with hematopathy (mainly, acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and myelodysplastic syndrome) to 18,108 individuals without known pathology. Genotyping was performed by polymerase chain reaction with specific sequence primers (PCR-SSP). As a result, we discovered four genes including KIR2DL5 (OR: 0.74, 95% CI 0.59-0.93; Pc = 0.0405), 2DS1 (OR: 0.74, 95% CI 0.59-0.93; Pc = 0.0405), 2DS3 (OR: 0.58, 95% CI 0.41-0.81; Pc = 0.0180), and 3DS1 (OR: 0.74, 95% CI 0.58-0.94; Pc = 0.0405) to be protective factors that significantly reduce the risk of aplastic anemia. Our findings offer new approaches to immunotherapy for hematological-related diseases. As these therapies mature, they are promising to be used alone or in combination with current treatments to help to make blood disorders a manageable disease.
Collapse
Affiliation(s)
- Ye-Mo Li
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | - Yu-Xia Li
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | - Xiao-Zhuang Hu
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | - Dai-Yang Li
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | - Zhi-Yang Yuan
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co, Ltd, Shanghai, China
| | | |
Collapse
|
13
|
Lei H, Jiang CH, Du KM, Zheng ZZ, Cai XH. The novel HLA-B*51:381 allele, identified in a Chinese individual through Sanger dideoxy nucleotide sequencing. HLA 2023. [PMID: 37315573 DOI: 10.1111/tan.15130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 05/31/2023] [Accepted: 06/02/2023] [Indexed: 06/16/2023]
Abstract
HLA-B*51:381 differs from HLA-B*51:01:01:01 by one nucleotide in exon 5.
Collapse
Affiliation(s)
- Hang Lei
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| | - Chuan-He Jiang
- Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | | | - Xiao-Hong Cai
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
14
|
An L, Ding PP, Xu X, Tu XN, Zheng ZZ. The novel HLA-C*06:02:105 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 37226401 DOI: 10.1111/tan.15114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 05/12/2023] [Indexed: 05/26/2023]
Abstract
HLA-C*06:02:105 differs from HLA-C*06:02:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Lin An
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Pei-Pei Ding
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Xiang Xu
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Xiao-Nian Tu
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
| | - Zhong-Zheng Zheng
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| |
Collapse
|
15
|
Liu C, Zheng ZZ, Xia NS. [Prophylactic vaccines for hepatitis type E]. Zhonghua Gan Zang Bing Za Zhi 2023; 31:477-482. [PMID: 37365023 DOI: 10.3760/cma.j.cn501113-20230304-00094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/28/2023]
Abstract
Over the past few years, hepatitis type E has been increasingly recognized as an underestimated global disease burden. Populations with severe infection-related injuries or deaths include pregnant women, patients with underlying liver disease, and the elderly. Vaccines are the most effective means to prevent hepatitis type E virus (HEV) infection. However, the development of inactivated or attenuated vaccines is not feasible due to the lack of an efficient HEV cell culture system, so researchers have conducted in-depth research on recombinant vaccines. The capsid protein (pORF2), which the virion's open reading frame 2 encodes, contains almost exclusively the HEV neutralization site. Several candidate vaccines based on pORF2 have demonstrated potential for primate protection, with two being well tolerated and highly effective in preventing hepatitis type E in adults. Hecolin® (HEV 239 vaccine), the world's first hepatitis type E vaccine, was approved for marketing in China in 2012.
Collapse
Affiliation(s)
- C Liu
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China
| | - Z Z Zheng
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China
| | - N S Xia
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China
| |
Collapse
|
16
|
Du KM, Ma L, Yuan ZY, An L, Zheng ZZ. The novel HLA-B*44:03:67 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 37204151 DOI: 10.1111/tan.15118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 05/12/2023] [Indexed: 05/20/2023]
Abstract
HLA-B*44:03:67 differs from HLA-B*44:03:02:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Ke-Ming Du
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Li Ma
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Zhi-Yang Yuan
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Zhong-Zheng Zheng
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| |
Collapse
|
17
|
Guo LJ, Zhang ZL, Zheng ZZ, Du KM, Cai XH. The novel HLA-A*02:07:23 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 37161862 DOI: 10.1111/tan.15098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Accepted: 04/30/2023] [Indexed: 05/11/2023]
Abstract
HLA-A*02:07:23 differs from HLA-A*02:07:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Liu-Jun Guo
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| | - Zi-Lu Zhang
- Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Xiao-Hong Cai
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Blood Transfusion Department, Ruijin Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
18
|
Hao CX, Zheng ZZ, Du KM, An L, Yang LJ. The novel HLA-DRB1*14:251 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 37102197 DOI: 10.1111/tan.15077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 04/12/2023] [Accepted: 04/14/2023] [Indexed: 04/28/2023]
Abstract
HLA-DRB1*14:251 differs from HLA-DRB1*14:126:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Cai-Xia Hao
- Department of Hematology, Xi'an International Medical Center Hospital, Xi'an, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Li-Jie Yang
- Department of Hematology, Xi'an International Medical Center Hospital, Xi'an, China
| |
Collapse
|
19
|
Chen LG, Jiang CF, Zheng ZZ, Du KM, Ouyang GF. The novel HLA-C*12:368 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 37070805 DOI: 10.1111/tan.14986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 12/02/2022] [Indexed: 04/19/2023]
Abstract
HLA-C*12:368 differs from HLA-C*12:03:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Lie-Guang Chen
- Department of Hematology, Ningbo First Hospital, Ningbo, China
| | - Cong-Fa Jiang
- Department of Hematology, Xiangshan First People's Hospital Medical Health Group, Ningbo, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Gui-Fang Ouyang
- Department of Hematology, Ningbo First Hospital, Ningbo, China
| |
Collapse
|
20
|
Hu P, Zheng ZZ, Du KM, An L, Yang TH. The novel HLA-DPB1*05:01:18 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 36951489 DOI: 10.1111/tan.15019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Accepted: 03/02/2023] [Indexed: 03/24/2023]
Abstract
HLA-DPB1*05:01:18 differs from HLA-DPB1*05:01:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Peng Hu
- Faculty of Life science and Technology, Kunming University of Science and Technology, Kunming, China
- Department of Hematology, First People's Hospital of Yunnan Province, Kunming, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Tong-Hua Yang
- Faculty of Life science and Technology, Kunming University of Science and Technology, Kunming, China
- Department of Hematology, First People's Hospital of Yunnan Province, Kunming, China
| |
Collapse
|
21
|
Zi FM, Zheng ZZ, Du KM, An L, Wang QM. The novel HLA-C*03:621 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 36889808 DOI: 10.1111/tan.15016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 03/01/2023] [Indexed: 03/10/2023]
Abstract
HLA-C*03:621 differs from HLA-C*03:04:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Fu-Ming Zi
- Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Qing-Ming Wang
- Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
| |
Collapse
|
22
|
Zhan WQ, Zheng ZZ, Du KM, An L, Huang XB. The novel HLA-DQB1*02:01:44 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:301-302. [PMID: 36385740 DOI: 10.1111/tan.14883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Revised: 11/15/2022] [Accepted: 11/15/2022] [Indexed: 11/19/2022]
Abstract
HLA-DQB1*02:01:44 differs from HLA-DQB1*02:01:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Wen-Qi Zhan
- Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Xian-Bao Huang
- Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
| |
Collapse
|
23
|
Zhou F, Zheng ZZ, Du KM, An L, Wang NJ. The novel HLA-C*01:239 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:289-290. [PMID: 36412259 DOI: 10.1111/tan.14901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 11/18/2022] [Indexed: 11/23/2022]
Abstract
HLA-C*01:239 differs from HLA-C*01:02:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Fang Zhou
- Department of Hematology, Hospital of People's Liberation Army, Jinan, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Ning-Juan Wang
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| |
Collapse
|
24
|
Yang AP, Zheng ZZ, Du KM, Chen JM, Zeng ZY. The novel HLA-DQB1*03:03:29 allele, identified by sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:302-304. [PMID: 36437783 DOI: 10.1111/tan.14907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Accepted: 11/25/2022] [Indexed: 11/29/2022]
Abstract
HLA-DQB1*03:03:29 differs from HLA-DQB1*03:03:02:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- A-Peng Yang
- Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.,Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Jun-Min Chen
- Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.,Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
| | - Zhi-Yong Zeng
- Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.,Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
| |
Collapse
|
25
|
Tang PX, Zheng ZZ, Du KM, An L, Xu ZS. The novel HLA-DQB1*04:93 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:305-307. [PMID: 36351873 DOI: 10.1111/tan.14877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Accepted: 11/05/2022] [Indexed: 11/11/2022]
Abstract
HLA-DQB1*04:93 differs from HLA-DQB1*04:01:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Pei-Xia Tang
- Department of Hematology, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Zhen-Shu Xu
- Department of Hematology, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, China
| |
Collapse
|
26
|
Wu YB, Zheng ZZ, Du KM, An L, Dai XP. The novel HLA-DRB1*14:07:03 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:294-296. [PMID: 36397184 DOI: 10.1111/tan.14890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 11/13/2022] [Accepted: 11/14/2022] [Indexed: 11/19/2022]
Abstract
HLA-DRB1*14:07:03 differs from HLA-DRB1*14:07:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Yuan-Bin Wu
- Department of Hematology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Xi-Ping Dai
- Department of Hematology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China
| |
Collapse
|
27
|
Shi ZY, Zheng ZZ, Du KM, Wu GQ, Zhao YM. The novel HLA-B*15:644 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:281-283. [PMID: 36382584 DOI: 10.1111/tan.14881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Accepted: 11/13/2022] [Indexed: 11/17/2022]
Abstract
HLA-B*15:644 differs from HLA-B*15:17:01:02 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Zhuo-Yue Shi
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.,Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.,Institute of Hematology, Zhejiang University, Hangzhou, China.,Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Gong-Qiang Wu
- Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang People's Hospital, Dongyang, China
| | - Yan-Min Zhao
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.,Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.,Institute of Hematology, Zhejiang University, Hangzhou, China.,Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
| |
Collapse
|
28
|
Li JJ, Zheng ZZ, Du KM, An L, Yue LL. The novel HLA-DQB1*03:499N allele identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:304-305. [PMID: 36397185 DOI: 10.1111/tan.14889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Accepted: 11/15/2022] [Indexed: 11/19/2022]
Abstract
HLA-DQB1*03:499N differs from HLA-DQB1*03:01:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Jing-Jing Li
- Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Ling-Ling Yue
- Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China
| |
Collapse
|
29
|
Bai J, Zheng Z, Du K, An L, Pan Y. The novel HLA-A*02:1068Q allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:271-272. [PMID: 36401836 DOI: 10.1111/tan.14893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2022] [Revised: 11/17/2022] [Accepted: 11/18/2022] [Indexed: 11/21/2022]
Abstract
HLA-A*02:1068Q differs from HLA-A*02:03:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- JiaoFeng Bai
- Department of Hematology, The 940th Hospital of PLA Joint Logistics Support Force, Lanzhou, China
| | | | - KeMing Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Yaozhu Pan
- Department of Hematology, The 940th Hospital of PLA Joint Logistics Support Force, Lanzhou, China
| |
Collapse
|
30
|
Fan ZP, Zheng ZZ, Du KM, An L, Liu QF. The novel HLA-B*40:01:78 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:285-286. [PMID: 36397642 DOI: 10.1111/tan.14884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2022] [Revised: 11/13/2022] [Accepted: 11/14/2022] [Indexed: 11/21/2022]
Abstract
HLA-B*40:01:78 differs from HLA-B*40:01:02:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Zhi-Ping Fan
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Qi-Fa Liu
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
| |
Collapse
|
31
|
Ma QY, Zheng ZZ, Du KM, An L, Cheng J. The novel HLA-B*55:131 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:286-287. [PMID: 36401794 DOI: 10.1111/tan.14892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 11/16/2022] [Accepted: 11/17/2022] [Indexed: 11/21/2022]
Abstract
HLA-B*55:131 differs from HLA-B*55:02:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Qian-Ying Ma
- The First Clinical Medical College, Lanzhou University, Lanzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Juan Cheng
- The First Clinical Medical College, Lanzhou University, Lanzhou, China.,Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, China
| |
Collapse
|
32
|
Liu C, Zheng ZZ, Du KM, An L, Li GH. The novel HLA-B*13:176 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023. [PMID: 36825393 DOI: 10.1111/tan.15006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 02/20/2023] [Accepted: 02/21/2023] [Indexed: 02/25/2023]
Abstract
HLA-B*13:176 differs from HLA-B*13:02:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Cong Liu
- Department of Hematology, Xi'an International Medical Center Hospital, Xi'an, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Guo-Hui Li
- Department of Hematology, Xi'an International Medical Center Hospital, Xi'an, China
| |
Collapse
|
33
|
Wang CL, Zheng ZZ, Du KM, An L, Zhang JR. The novel HLA-C*01:02:89 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:174-175. [PMID: 36303272 DOI: 10.1111/tan.14870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 10/23/2022] [Accepted: 10/25/2022] [Indexed: 01/25/2023]
Abstract
HLA-C*01:02:89 differs from HLA-C*01:02:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Cai-Li Wang
- Department of Hematology, Guiyang Maternal And Child Health Care Hospital, Guiyang, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Jing-Rong Zhang
- Department of Hematology, Guiyang Maternal And Child Health Care Hospital, Guiyang, China
| |
Collapse
|
34
|
Shi XD, Zheng ZZ, Du KM, An L, Wang NJ. The novel HLA-DRB1*14:246 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:78-80. [PMID: 36097679 DOI: 10.1111/tan.14816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Revised: 09/09/2022] [Accepted: 09/11/2022] [Indexed: 12/13/2022]
Abstract
HLA-DRB1*14:246 differs from HLA-DRB1*14:18 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Xiao-Dong Shi
- Affiliated Children's Hospital of Capital Institute of Pediatrics, Beijing, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Ning-Juan Wang
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| |
Collapse
|
35
|
Liu C, Zheng ZZ, Du KM, An L, Zhou M. The novel HLA-B*15:638 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:51-53. [PMID: 36056764 DOI: 10.1111/tan.14797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 08/29/2022] [Accepted: 08/30/2022] [Indexed: 12/13/2022]
Abstract
HLA-B*15:638 differs from HLA-B*15:01:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Can Liu
- Department of Hematology, The Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Ming Zhou
- Department of Hematology, The Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China
| |
Collapse
|
36
|
Zhang JH, Zheng ZZ, Du KM, An L, Yang LH. The novel HLA-B*52:110N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:58-59. [PMID: 36056772 DOI: 10.1111/tan.14800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 08/29/2022] [Accepted: 08/30/2022] [Indexed: 12/13/2022]
Abstract
HLA-B*52:110N differs from HLA-B*52:01:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Jian-Hua Zhang
- Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin-Hua Yang
- Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
| |
Collapse
|
37
|
Lu JY, Zheng ZZ, Du KM, An L, Lu QY. The novel HLA-DPB1*1352:01 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:97-99. [PMID: 36074554 DOI: 10.1111/tan.14808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 09/05/2022] [Accepted: 09/06/2022] [Indexed: 12/13/2022]
Abstract
HLA-DPB1*1352:01 differs from HLA-DPB1*02:01:02:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Jing-Yuan Lu
- Department of Hematology, Zhongshan Hospital Xiamen University, Xiamen, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Quan-Yi Lu
- Department of Hematology, Zhongshan Hospital Xiamen University, Xiamen, China
| |
Collapse
|
38
|
Yu JX, Zheng ZZ, Du KM, An L, Bi H. The novel HLA-B*55:130 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:59-60. [PMID: 36054328 DOI: 10.1111/tan.14796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 08/29/2022] [Accepted: 08/30/2022] [Indexed: 12/13/2022]
Abstract
HLA-B*55:130 differs from HLA-B*55:35 by two nucleotides in exon 2.
Collapse
Affiliation(s)
- Jing-Xing Yu
- Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Hui Bi
- Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
| |
Collapse
|
39
|
Cai Y, Zheng ZZ, Du KM, An L, Yang J. The novel HLA-C*03:04:74 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:63-64. [PMID: 36066974 DOI: 10.1111/tan.14804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Revised: 09/01/2022] [Accepted: 09/02/2022] [Indexed: 12/13/2022]
Abstract
HLA-C*03:04:74 differs from HLA-C*03:04:01:01 by one nucleotide in exon 6.
Collapse
Affiliation(s)
- Yu Cai
- Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Juan Yang
- Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| |
Collapse
|
40
|
Zhang H, Zheng ZZ, Du KM, An L, Liu B. The novel HLA-B*35:563 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2023; 101:55-56. [PMID: 36054158 DOI: 10.1111/tan.14795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 08/29/2022] [Accepted: 08/30/2022] [Indexed: 12/13/2022]
Abstract
HLA-B*35:563 differs from HLA-B*35:03:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Hao Zhang
- Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Bei Liu
- Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
| |
Collapse
|
41
|
Liu L, Zheng ZZ, Du KM, An L, Wang SB. The novel HLA-A*24:582 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:529-530. [PMID: 36479959 DOI: 10.1111/tan.14931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 12/04/2022] [Accepted: 12/05/2022] [Indexed: 12/13/2022]
Abstract
HLA-A*24:582 differs from HLA-A*24:02:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Lin Liu
- Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - San-Bin Wang
- Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, China
| |
Collapse
|
42
|
Xu S, Zheng ZZ, Du KM, An L, Deng MY. The novel HLA-B*48:01:11 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:540-541. [PMID: 36479837 DOI: 10.1111/tan.14926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-B*48:01:11 differs from HLA-B*48:01:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Shan Xu
- Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Ming-Yang Deng
- Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
43
|
Zhu ZM, Zheng ZZ, Du KM, An L, Cheng LN. The novel HLA-A*02:07:22 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:514-516. [PMID: 36478446 DOI: 10.1111/tan.14918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-A*02:07:22 differs from HLA-A*02:07:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Zun-Min Zhu
- Department of Hematology, Institute of Hematology, Provincial People's Hospital, Henan, Zhengzhou, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Lin-Na Cheng
- Department of Hematology, Institute of Hematology, Provincial People's Hospital, Henan, Zhengzhou, China
| |
Collapse
|
44
|
Yu W, Zheng ZZ, Du KM, An L, Liu AG. The novel HLA-DQB1*06:208:02 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022. [PMID: 36478113 DOI: 10.1111/tan.14915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 12/02/2022] [Indexed: 12/13/2022]
Abstract
HLA-DQB1*06:208:02 differs from HLA-DQB1*06:02:02 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Wen Yu
- Department of Pediatrics, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Ai-Guo Liu
- Department of Pediatrics, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
45
|
Yang Z, Zheng ZZ, Du KM, An L, Wang Y. The novel HLA-C*04:490 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:546-548. [PMID: 36479613 DOI: 10.1111/tan.14925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-C*04:490 differs from HLA-C*04:01:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Zhou Yang
- Department of Hematology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Yue Wang
- Department of Hematology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China
| |
Collapse
|
46
|
Zhao YQ, Zheng ZZ, Du KM, An L, Fan SJ. The novel HLA-C*15:02:58 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:552-553. [PMID: 36478103 DOI: 10.1111/tan.14927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/13/2022]
Abstract
HLA-C*15:02:58 differs from HLA-C*15:02:01:01 by one nucleotide in exon 1.
Collapse
Affiliation(s)
- Yan-Qiu Zhao
- Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Sheng-Jin Fan
- Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
| |
Collapse
|
47
|
Zhang YF, Zheng ZZ, Du KM, An L, Gao D. The novel HLA-B*13:01:21 allele identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:536-537. [PMID: 36479611 DOI: 10.1111/tan.14920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 12/02/2022] [Indexed: 12/13/2022]
Abstract
HLA-B*13:01:21 differs from HLA-B*13:01:01:01 by one nucleotide in exon 2.
Collapse
Affiliation(s)
- Yan-Fen Zhang
- Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Da Gao
- Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
| |
Collapse
|
48
|
Bai FX, Zheng ZZ, Du KM, An L, Zeng HQ. The novel HLA-A*24:02:160 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:525-527. [PMID: 36479606 DOI: 10.1111/tan.14928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-A*24:02:160 differs from HLA-A*24:02:01:01 by one nucleotide in exon 3.
Collapse
Affiliation(s)
- Feng-Xia Bai
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Han-Qing Zeng
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
49
|
He M, Zheng ZZ, Du KM, An L, Lian GL. The novel HLA-A*02:1075 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:516-517. [PMID: 36478195 DOI: 10.1111/tan.14912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-A*02:1075 differs from HLA-A*02:07:01:01 by one nucleotide in exon 5.
Collapse
Affiliation(s)
- Min He
- Department of Paediatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Guo-Li Lian
- Department of Paediatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| |
Collapse
|
50
|
Zhang Y, Zheng ZZ, Du KM, An L, Huang CM. The novel HLA-B*35:568 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA 2022; 101:539-540. [PMID: 36478419 DOI: 10.1111/tan.14914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
HLA-B*35:568 differs from HLA-B*35:03:01:01 by one nucleotide in exon 4.
Collapse
Affiliation(s)
- Ying Zhang
- Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | | | - Ke-Ming Du
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Lin An
- Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, China
| | - Chong-Mei Huang
- Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|